Suggested Considerations for the Treatment of Rheumatic Diseases in Adult Patients With COVID-19: Comment on the Article by Mikuls et al.
作者信息
Hsu Jeffrey, Liu Chin-Hsiu, Wei James C
机构信息
University of Virginia School of Medicine, Charlottesville, VA.
China Medical University Hospital and China Medical University, Taichung, Taiwan.
出版信息
Arthritis Rheumatol. 2021 Dec;73(12):2355. doi: 10.1002/art.41889. Epub 2021 Oct 28.
Abstract
摘要
相似文献
1
Suggested Considerations for the Treatment of Rheumatic Diseases in Adult Patients With COVID-19: Comment on the Article by Mikuls et al.
Arthritis Rheumatol. 2021 Dec;73(12):2355. doi: 10.1002/art.41889. Epub 2021 Oct 28.
2
Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al.
Arthritis Rheumatol. 2021 Mar;73(3):547-548. doi: 10.1002/art.41575. Epub 2021 Jan 29.
3
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie .
Ann Rheum Dis. 2021 Jan;80(1):e7. doi: 10.1136/annrheumdis-2020-217633. Epub 2020 Jun 22.
4
Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis .
Ann Rheum Dis. 2021 Apr;80(4):e61. doi: 10.1136/annrheumdis-2020-217987. Epub 2020 May 31.
5
Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops .
Ann Rheum Dis. 2021 May;80(5):e68. doi: 10.1136/annrheumdis-2020-218148. Epub 2020 Jun 26.
6
Morbidity and Mortality From COVID-19 Are Not Increased Among Children or Patients With Autoimmune Rheumatic Disease-Possible Immunologic Rationale: Comment on the Article by Henderson et al.
Arthritis Rheumatol. 2020 Oct;72(10):1772-1774. doi: 10.1002/art.41399. Epub 2020 Sep 6.
7
Use of Tofacitinib in the Context of COVID-19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases.
Arthritis Rheumatol. 2021 Sep;73(9):1768-1769. doi: 10.1002/art.41806. Epub 2021 Jul 29.
8
Reply to comment on: Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
Clin Exp Rheumatol. 2023 Mar;41(3):762. doi: 10.55563/clinexprheumatol/de3qq9. Epub 2023 Jan 4.
9
Comment on: Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
Clin Exp Rheumatol. 2023 Mar;41(3):762. doi: 10.55563/clinexprheumatol/tfggsk. Epub 2023 Jan 4.
10
Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha .
Ann Rheum Dis. 2021 Oct;80(10):e171. doi: 10.1136/annrheumdis-2021-219866. Epub 2021 Jan 28.
本文引用的文献
1
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
Front Immunol. 2021 Apr 2;12:631869. doi: 10.3389/fimmu.2021.631869. eCollection 2021.
2
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
Lancet Rheumatol. 2021 Jun;3(6):e419-e426. doi: 10.1016/S2665-9913(21)00059-X. Epub 2021 Mar 25.
3
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
4
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.
Arthritis Rheumatol. 2021 Feb;73(2):e1-e12. doi: 10.1002/art.41596. Epub 2020 Dec 5.
5
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.
Sci Adv. 2021 Jan 1;7(1). doi: 10.1126/sciadv.abe4724. Print 2021 Jan.
6
Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic.
Front Med (Lausanne). 2020 Oct 9;7:562142. doi: 10.3389/fmed.2020.562142. eCollection 2020.
7
Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren's Syndrome.
J Clin Med. 2020 Oct 28;9(11):3469. doi: 10.3390/jcm9113469.
Zotero 插件